Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.045
-0.075 (-3.54%)
Oct 30, 2025, 1:06 PM EDT - Market open

Palisade Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
27255818-
Upgrade
Market Cap Growth
6699.76%-16.56%-31.77%-54.57%--
Upgrade
Enterprise Value
277-3-9-54-
Upgrade
Last Close Price
2.121.658.8578.00975.00-
Upgrade
PS Ratio
--21.88---
Upgrade
PB Ratio
3.890.610.480.642.40-
Upgrade
P/TBV Ratio
107.700.610.480.642.40-
Upgrade
Debt / Equity Ratio
0.130.020.030.030.03-0.20
Upgrade
Asset Turnover
--0.02---
Upgrade
Quick Ratio
1.373.054.874.594.260.10
Upgrade
Current Ratio
1.623.245.154.894.610.11
Upgrade
Return on Equity (ROE)
-188.48%-153.56%-103.40%-143.72%-20012.03%-
Upgrade
Return on Assets (ROA)
-77.59%-74.50%-53.85%-67.69%-94.46%-161.72%
Upgrade
Return on Capital (ROIC)
-113.05%-96.02%-65.36%-93.60%-777.90%-
Upgrade
Earnings Yield
-4.20%-316.35%-224.87%-177.89%-150.84%-
Upgrade
FCF Yield
-3.43%-267.16%-203.61%-166.78%-83.72%-
Upgrade
Buyback Yield / Dilution
-326.35%-210.62%-677.03%-370.85%--
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q